Search academic texts

Head: Syvak Lubov А.. Optimization of conservative treatment of HER2 / neu breast cancer patients (negative) at high risk of disease progression.. (popup.stage: ). National Cancer Institute. № 0223U002359

Head: Syvak Lubov А.. Optimization of conservative treatment of HER2 / neu breast cancer patients (negative) at high risk of disease progression.. (popup.stage: ). National Cancer Institute. № 0222U003718

Head: Syvak Lubov А.. Optimization of conservative treatment of HER2 / neu breast cancer patients (negative) at high risk of disease progression.. (popup.stage: ). National Cancer Institute. № 0221U104838

Head: Syvak Lubov А.. To optimize treatment in patients with metastatic breast cancer molecular subtypes adverse prognostic. (popup.stage: ). National Cancer Institute. № 0220U102648

Holotiuk Volodymyr Volodymyrovych. Optimization of the Redox Status in Patients with Rectal Cancer: Molecular Mechanisms of Complex Treatment Efficiency : д.мед.н. : spec.. 14.01.07 - Онкологія : presented. 2017-11-01; popup.evolution: .; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. – , 0517U000739.

Kalinin Oleksie Evgenоvych. Endoscopic recanalization supplemented with entero- and colonosorption for treatment of patients with rectal cancer complicated with intestinal obstruction : к.мед.н. : spec.. 14.01.07 - Онкологія : presented. 2014-09-24; popup.evolution: .; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. – , 0414U004524.

Yatsenko Ludmila Dmitrievna. Antitumor activity of poliplatillen and its efficacy in the treatment of advanced stomach, pancreatic and lung cancer patients (experimental and clinical study). : д.мед.н. : spec.. 14.01.07 - Онкологія : presented. 2009-02-25; popup.evolution: .; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology. – , 0509U000146.